Literature DB >> 1655248

Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose.

K Nakachi1, K Imai, S Hayashi, J Watanabe, K Kawajiri.   

Abstract

Cytochrome P450IA1 is responsible for the metabolic activation of benzo(a)pyrene in cigarette smoke; an association of lung cancer with DNA polymorphisms of P450IA1 gene was shown in our previous study. In this paper, we investigated the interindividual difference of genetically determined susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. We first compared the total amounts of cigarettes consumed over the lifetime of patients and showed that the patients with a "susceptible" P450IA1 gene genotype contracted carcinoma after fewer cigarettes [mean +/- SD, 31.3 +/- 12.8 x 10(4) cigarettes (n = 12)] than those with other genotypes [42.5 +/- 18.2 x 10(4) (n = 33)], with a statistical significance of P less than 0.05. Next, we carried out a case-control study to estimate the odds ratios of susceptible to nonsusceptible individuals in relation to the cumulated cigarette dose. We thus showed that the individuals with the susceptible genotype were at remarkably high risk with an odds ratio of 7.31 (95% confidence interval, 2.13 to 25.12) at a low dose level of cigarette smoking and that the difference in susceptibility between genotypes was reduced at high dose levels.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655248

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

Review 1.  HPV infections and lung cancer.

Authors:  K J Syrjänen
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

Review 2.  Molecular genetics of cancer.

Authors:  B A Ponder
Journal:  BMJ       Date:  1992-05-09

3.  Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population.

Authors:  Al-Motassem Yousef; Nailya R Bulatova; William Newman; Nancy Hakooz; Said Ismail; Hisham Qusa; Farah Zahran; Nidaa Anwar Ababneh; Farah Hasan; Imad Zaloom; Ghada Khayat; Rawan Al-Zmili; Randa Naffa; Ola Al-Diab
Journal:  Mol Biol Rep       Date:  2012-06-22       Impact factor: 2.316

4.  Association study of detoxification genes in age related macular degeneration.

Authors:  H Esfandiary; U Chakravarthy; C Patterson; I Young; A E Hughes
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

5.  Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north indian population.

Authors:  R C Sobti; S Sharma; A Joshi; S K Jindal; A Janmeja
Journal:  Mol Cell Biochem       Date:  2004-11       Impact factor: 3.396

6.  Role of xenobiotic-metabolizing enzyme gene polymorphisms and interactions with environmental factors in susceptibility to gastric cancer in Kashmir Valley.

Authors:  Manzoor A Malik; Rohit Upadhyay; Rama D Mittal; Showket A Zargar; Dinesh R Modi; Balraj Mittal
Journal:  J Gastrointest Cancer       Date:  2009-06-12

7.  Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of lung cancer.

Authors:  Chikako Kiyohara; Taro Shirakawa; Julian M Hopkin
Journal:  Environ Health Prev Med       Date:  2002-05       Impact factor: 3.674

8.  Identification of polymorphism at the glutathione S-transferase, GSTM3 locus: evidence for linkage with GSTM1*A.

Authors:  A Inskip; J Elexperu-Camiruaga; N Buxton; P S Dias; J MacIntosh; D Campbell; P W Jones; L Yengi; J A Talbot; R C Strange
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

9.  Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese.

Authors:  T Oyama; T Mitsudomi; T Kawamoto; A Ogami; T Osaki; Y Kodama; K Yasumoto
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

10.  Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases.

Authors:  K Imai; K Nakachi
Journal:  BMJ       Date:  1995-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.